Expression and characterization of bioactive human thrombopoietin in the milk of transgenic mice

DNA and Cell Biology

Volumn 18, Issue 11, 1999, Pages 845-852

  Sohn, Bo Hwa ^a   Kim, Sun Jung ^a   Park, Heungrok ^a   Park, Seung Kook ^b   Lee, Sang Chul ^a   Hong, Hyo Jeong ^a   Park, Young Sik ^c   Lee, Kyung Kwang ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Daewoong Pharmaceutical Co Ltd   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; LACTATION; MALE; MILK; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BLOOD PLATELETS; BLOTTING, NORTHERN; CASEINS; CATTLE; CELL DIVISION; FEMALE; GENETIC ENGINEERING; HUMANS; IMMUNOBLOTTING; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK; ORGAN SPECIFICITY; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; THROMBOPOIETIN;

ANIMALIA; BOVINAE; MUS MUSCULUS; RODENTIA;

EID: 2442748928     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999314845     Document Type: Article

References (33)

1. APPLEBY, P., and CATTY, D. (1983). Transmission of immunoglobulin to foetal and neonatal mice. J. Reprod. Immunol. 5, 203-213.
2. 1-antitrypsin in the milk of transgenic mice. Proc. Natl. Acad. Sci. USA 87, 5178-5182.
3. BARTLEY, T.D., BOGENBERGER, J., HUNT, P., LI, Y.S., LU, H.S., MARTIN, F., CHANG, M.S., SAMAL, B., NICHOL, J.L., SWIFT, S., Y. PARKER, V.P., SUGGS, S., SKRINE, J.D., MEREWETHER, L.A., CLOGSTON, C., HSU, E., HOKOM, M.M., HORNKOHL, A., CHOI, E., PANGELINAN, M., SUN, Y., MAR, V., MCNINCH, J., SIMONET, L., JACOBSEN, F., XIE, C., SHUTTER, J., CHUTE, H., BASU, R., SELANDER, L., TROLLINGER, D., SIEU, L., PADILLA, D., TRAIL, G., ELLIOTT, G., IZUMI, R., COVEY, T., CROUSE, J., GARCIA, A., XU, W., CASTILLO, J., BIRON, J., COLE, S., HU, M.C.-T., PACIFICI, R., PONTING, I., SARIS, C., WEN, D., YUNG, Y.P., LIN, H., and BOSSELMAN, R.A. (1994). Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117-1124.
4. BASSER, R.L., RASKO, J.E., CLARKE, K., CEBON, J., GREEN, M.D., HUSSEIN, S., ALT, C., MENCHACA, D., TOMITA, D., MARTY, J., FOX, R.M., and BEGLEY, C.G. (1996). Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rhuMGDF) in patients with advanced cancer. Lancet 348, 1279-1281.
5. BUHLER, T.A., BRUYERE, T., WENT, D.F., STRANZINGER, G., and BURKI, K. (1990). Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Biotechnology 8, 140-143.
6. DE SAUVAGE, F.J., HASS, P.E., SPENCER, S.D., MALLOY, B.E., GURNEY, A.L., SPENCER, S.A., DARBONNE, W.C., HENZEL, W.J., WONG, S.C., KUANG, W.J., OLES, K.J., HULTGREN, B., SOLBERG JR., L.A., GOEDDEL, D.V., and EATON, D.L. (1994). Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369, 533-538.
7. FANUCCHI, M., GLASPY, J., CRAWFORD, J., GARST, J., FIGLIN, R., SHERIDAN, W., MENCHACA, D., TOMITA, D., OZER, H., and HARKER, L. (1997). Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N. Engl. J. Med. 336, 404-409.
8. FARESE, A.M., HUNT, P., BOONE, T., and MACVITTIE, T.J. (1995). Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 86, 54-59.
9. GORDON, K., LEE, E., VITALE, J.A., SMITH, A.E., WESTPHAL, H., and HENNINGHAUSEN, L. (1992). Production of human tissue plasminogen activator in transgenic mouse milk. Biotechnology 24, 425-428.
10. GURNEY, A.L., KUANG, W.J., XIE, M.H., MALLOY, B.E., EATON, D.L., and DE SAUVAGE, F.J. (1995). Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 85, 981-988.
11. HOFFMAN, R.C., ANDERSON, H., WALKER, K., KRAKOVER, J.D., PATEL, S., STAMM, M.R., and OSBORN, S.G. (1996). Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from serl to Arg246. Biochemistry 35, 14849-14861.
12. HOGAN, B., BEDDINGTON, R., CONSTANTINI, F., and LACY, E. (1994). Manipulating the Mouse Embryo: Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 27-252.
13. HOKOM, M.M., LACEY, D., KINSTLER, O.B., CHOI, E., KAUFMAN, S., FAUST, J., ROWAN, C., DWYER, E., NICHOL, J.L., GRASEL, T., WILSON, J., STEINBRINK, R., HECHT, R., WINTERS, D., BOONE, T., and HUNT, P. (1995). Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 86, 4486-4492.
14. HOSHI, S., YOSHITOMI, H., KOMATSU, N., YOSHITAKE, S., and OKADA, M. (1997). Megakaryocytopoietic activity of a truncated variant of mouse thrombopoietin. Biochem. Biophys. Res. Commun. 231, 823-826.
15. JACOBS, K., SHOEMAKER, C., RUDERSDORF, R., NEILL, S.D., KAUFMAN, R.J., MUFSON, A., SEEHRA, J., JONES, S.S., HEWICK, R., FRITSCH, E.F., KAWAKITA, M., SHIMIZU, T., and MIYAKE, T. (1985). Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313, 806-810.
16. KIM, S.J., SOHN, B.H., JEONG, S., PAK, K.-W., PARK, J.-S., PARK, I.-Y., LEE, T.-H., CHOI, Y.-H., LEE, C.-S., HAN, Y.-M., YU, D.-Y., and LEE, K.-K. (1999). A high level expression of human lactoferrin in milk of transgenic mice using genomic lactoferrin sequence. J. Biochem. 126, 320-325.
17. KORHONEN, V.-P., TOLVANEN, M., HYTTINEN, J.-M., UUSIOUKARI, M., SINERVIRTA, R., ALHONEN, L., JAUHIAINEN, M., HANNE, O.A., and JANNE, J. (1997). Expression of bovine β-lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits. Eur. J. Biochem. 245, 482-489.
18. LI, S., LI, F., WU, W., TAN, W., YU, M., CHEN, J., and TAO, K. (1997). Expression in Escherichia coli and purification of human thrombopoietin. Biotechnol. Appl. Biochem. 26, 15-17.
19. LOK, S., and FOSTER, D.C. (1994). The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 12, 586-598.
20. LOK, S., KAUSHANSKY, K., HOLLY, R.D., KUIJPER, J.L., LOFTON-DAY, C.E., OORT, P.J., GRANT, F.J., HEIPEL, M.D., BURKHEAD, S.K., KRAMER, J.M., BELL, L.A., SPRECHER, C.A., BLUMBERG, H., JOHNSON, R., PRUNKARD, D., CHING, A.F.T., MATHEWES, S.L., BAILEY, M.C., FORSTROM, J.W., BUDDLE, M.M., OSBORN, S.G., EVANS, S.J., SHEPPARD, P.O., PRESNELL, S.R., O'HARA, P.J., HAGEN, F.S., ROTH, G.J., and FOSTER, D.C. (1994). Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565-568.
21. MADAN, A., LIN, C., HATCH, S.L., 2nd, and CURTIN, P.T. (1995). Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 85, 2735-2741.
22. MIN, W., WOO, H.J., LEE, C.-S., LEE, K.-K., YOON, W.K., PARK, H.W., and KIM, M.H. (1998). 307-Bp fragment in HOXA7 upstream sequence is sufficient for anterior boundary formation. DNA Cell Biol. 17, 293-299.
23. + cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis. Exp. Hematol. 26, 207-216.
24. O'MALLEY, C.J., RASKO, J.E., BASSER, R.L., MCGRATH, K.M., CEBON, J., GRIGG, A.P., HOPKINS, W., COHEN, B., O'BYRNE, J., GREEN, M.D., FOX, R.M., BERNDT, M.C., and BEGLEY, C.G. (1996). Administration of pegylated human megakeryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 88, 3288-3298.
25. PARK, H., and HONG, H.J. (1997). Development of an in vitro bioassay system for human thrombopoietin by constructing a recombinant murine cell line expressing human thrombopoietin receptor. Mol. Cells. 7, 699-704.
26. PARK, H., PARK, S.S., JIN, E.H., SONG, J.-S., RYU, S.-E., YU, M.-H., and HONG, H.J. (1998). Identification of functionally important residues of human thrombopoietin. J. Biol. Chem. 273, 256-261.
27. RODRIGUEZ, A., CASTRO, F.O., AGUILAR, A., RAMOS, B., DEL BARCO, D.G., LLEONART, R., and DE LA FUENTE, J. (1995). Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol. Res. 28, 141-153.
28. SHIMADA, Y., KATO, T., OGAMI, K., HORIE, K., KOKUBO, A., KUDO, Y., MAEDA, E., SOHMA, Y., AKAHORI, H., KAWAMURA, K., and MIYAZAKI, H. (1995). Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp. Hematol. 23, 1388-1396.
29. SOHMA, Y., AKAHORI, H., SEKI, N., HORI, T., OGAMI, K., KATO, T., SHIMADA, Y., KAWAMURA, K., and MIYAZAKI, H. (1994). Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 353, 57-61.
30. ULICH, T.R., DEL CASTILLO, J., SENALDI, G., CHEUNG, E., ROSKOS, L., YOUNG, J., MOLINEUX, G., GUO, J., SCHOEMPERLEN, J., MUNYAKAZI, L., MURPHY-FILKINS, R., TARPLEY, J.E., TOOMBS, C.F., KAUFMAN, S., YIN, S., NELSON, A.C., NICHOL, J.L., and SHERIDAN, W.P. (1999). The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice. Exp. Hematol. 27, 117-130.
31. s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony stimulating factor in the milk of transgenic mice. Transgene Res. 6, 75-84.
32. VELANDER, W.H., PAGE, R.L., MORCOL, T., RUSSELL, C.G., CAJSECO, R., YOUNG, J.M., DROHAN, W.N., GWAZDAUSKAS, F.C., WILKINS, T.D., and HOHNSON, J.L. (1992). Production of biologically active human protein C in the milk of transgenic mice. Ann. N.Y. Acad Sci. 665, 391-403.
33. ZHOU, W., TOOMBS, C.F., ZOU, T., GUO, J., and ROBINSON, M.O. (1997). Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89, 1551-1559.